2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

講師

P.M. Murali

Session 5 – Regional Collaboration & Opportunity
Date: 25 July (Thursday)  09:00 – 12:15
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom B
 


 

Dr. P.M. Murali

Chairman
Jananom Private Limited

 
P M Murali, is the Chairman of Jananom Private limited a young start up established in Bengaluru. He previously worked as the Managing Director of the Swiss International Company Evolva Biotech, one of the pioneering firms in biomolecular engineering in the world to generate products from microbial factories that are applied across diverse verticals from pharmaceuticals, nutraceuticals, flavours & fragrances, agriculture, veterinary, FMCG goods and defence.  He was instrumental in establishing this as India’s unique public private partnership model into a CSIR institute in Hyderabad before moving the establishment to Chennai.   He was one of the first in the world to build a successful pipeline for pushing “molecules to market” to reap their commercial benefits, by building a rich ecosystem of contract research institutions and public research institutions not just in India but in several other countries as well.  Many of these partnerships and collaborations were also anchored by Governments in Asia for welfare of the society. Some noteworthy examples include his work with Government of Singapore to build their synthetic biology ecosystem and in Malaysia to support producing a high value fragrance compound using fermentation thereby reducing deforestation.  Many of these efforts had potentially saved tons of carbon footprint for the planet and in progressing towards achieving sustainable development goals for emerging economies. All these efforts led to winning the prestigious “company of the year” award globally.  

Prior to Evolva, he founded & directed the R&D team at the Dalmia Centre for Research where he pioneered many herbal products and launched them successfully post all 4 phases of rigorous double-blind placebo controlled clinical trials.  Thousands of patients and users benefited for many diseases affecting respiratory, cardiac, dental and cognitive systems.  Tobacco replacement, social forestry, expanding Neem’s use were some of his noteworthy contributions. He won several awards & accolades for his services.

Dr. Murali was President of ABLE (the only industry body for biotech companies in India with more than 1000 members) for two terms and currently serves on its EC. His tenure as President facilitated the path of “vision US $ 100 Billion” for the Biotech sector.  There is a lot of granularity that has been bought into this model since it was conceived.

He also serves as the Chairman for the Women’s Biotech Park in Tamil Nadu, a unique and pioneering initiative of the Government to promote women entrepreneur in biotechnology.  Currently a lot of effort is going into the creation of this park into a world class tech facility.

Dr. Murali also serves in the Karnataka Vision group of Biotechnology and has played a pivotal role in the recent policy release. He is advising several state governments on policies related to biotechnology. Under his leadership several policy documents on manufacturing, biosimilars, make in India have been released. Dr. Murali serves in several government committees on Biotechnology.

Dr. Murali is a keen follower on Biodiversity issues. Has represented the Industry with the National Biodiversity Authority on a number of issues to find solutions that is a win win for the country and the Companies.

His social work includes his work at Indian Red Cross, where he presently serves as the Vice President. The focus is on girl children with disabilities and orphaned to provide education and support.